UCP1 and metabolic disease: Strategies for combating metabolic diseases through the activation of UCP1 have been proposed; for instance, eight subjects with diabetes reported a 43% increase in insulin sensitivity when UCP1 was activated by cold acclimation (14–15 °C) for 10 days [66].